In vivo amplification of the androgen receptor gene and progression of human prostate cancer. - Wikidata - awgldk - TriplyDB

In vivo amplification of the androgen receptor gene and progression of human prostate cancer.

In vivo amplification of the androgen receptor gene and progression of human prostate cancer.

http://www.wikidata.org/entity/Q34314274

about

Androgen-targeted therapy-induced epithelial mesenchymal plasticity and neuroendocrine transdifferentiation in prostate cancer: an opportunity for intervention LNCaP Atlas: gene expression associated with in vivo progression to castration-recurrent prostate cancer Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor Estrogen receptor alpha gene amplification in breast cancer: 25 years of debate LEF1 in androgen-independent prostate cancer: regulation of androgen receptor expression, prostate cancer growth, and invasion Identification and characterization of ART-27, a novel coactivator for the androgen receptor N terminus Melanoma antigen gene protein MAGE-11 regulates androgen receptor function by modulating the interdomain interaction Androgen receptor molecular biology and potential targets in prostate cancer Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancer Molecular biology of lung cancer: clinical implications Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer The genomic complexity of primary human prostate cancer Molecular pathology of prostate cancer Genomic amplification of the human telomerase gene (TERC) in pap smears predicts the development of cervical cancer Amplification of EIF3S3 gene is associated with advanced stage in prostate cancer Androgen receptor signaling is required for androgen-sensitive human prostate cancer cell proliferation and survival Acquisition of androgen independence by human prostate epithelial cells during arsenic-induced malignant transformation.Molecular mechanisms underlying resistance to androgen deprivation therapy in prostate cancer Splice Variants of Androgen Receptor and Prostate Cancer Advances in genetics: widening our understanding of prostate cancer Understanding prostate-specific antigen dynamics in monitoring metastatic castration-resistant prostate cancer: implications for clinical practice Mechanisms of resistance in castration-resistant prostate cancer (CRPC)Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer Notes for developing a molecular test for the full characterization of circulating tumor cells The mutational landscape of prostate cancer Abiraterone in the treatment of metastatic castration-resistant prostate cancer Oncolytic adenovirus-mediated therapy for prostate cancer Targeting the androgen receptor in prostate and breast cancer: several new agents in development Genetically engineered mouse models of prostate cancer Potent anti-proliferative, pro-apoptotic activity of the Maytenus royleanus extract against prostate cancer cells: evidence in in-vitro and in-vivo models Targeting the binding function 3 (BF3) site of the human androgen receptor through virtual screening.The metalloproteinase ADAMTS1: a comprehensive review of its role in tumorigenic and metastatic pathways.FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome.The importance of non-nuclear AR signaling in prostate cancer progression and therapeutic resistance Radionuclide Therapies in Prostate Cancer: Integrating Radium-223 in the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer Meta-analysis of prostate cancer gene expression data identifies a novel discriminatory signature enriched for glycosylating enzymes The potential for chemical mixtures from the environment to enable the cancer hallmark of sustained proliferative signalling BAG-1L protein enhances androgen receptor function Effect of small molecules modulating androgen receptor (SARMs) in human prostate cancer models Prostatic intraepithelial neoplasia in mice expressing an androgen receptor transgene in prostate epithelium

P2860

Q21129293-21765C21-EB1D-49C5-8D9D-482C636784CF Q21202034-B5B62FFF-7397-4256-8146-8676B88DC9E9 Q22254190-E63E2D5D-4348-4EDC-8E01-4E38D36B22A5 Q24273274-29E1C9C8-9EC4-47F8-AC2C-D4691DCEE1A2 Q24313620-5968B746-3B56-4421-869B-E52293D9A6AD Q24555034-3EE713A8-3639-4671-96EE-DE9EBFD45BD0 Q24556963-1028BCB9-3100-41CD-9868-4C85DD09BBA5 Q24602861-A688CF3D-5F52-447A-8C03-1749339CC9B2 Q24610167-C72E9036-49A1-42F9-B971-CC0303207173 Q24610335-D9DD0727-736E-4859-B38F-AC3BB38D0E51 Q24616117-D02B2D94-057A-4EB1-BE47-032797975C4B Q24617949-15BAF9E8-EE78-442E-8CA0-21CBA17E134C Q24672410-CD4032A4-D50D-4B55-AF15-B2047A94AAF7 Q24675639-C1B453C1-197E-4B54-8929-D95AF3D1838C Q24685619-3AACD43E-02CC-49C4-8EE7-E2A751055E29 Q24793296-48827F4B-8B6A-40E4-99CB-E07DD637761E Q24815477-A3BE921C-14CF-4A82-83AA-AB66A50D500E Q26739708-932F37B6-532C-47E7-96F6-1665D8ACDCE2 Q26740592-249C1F5B-7F47-4B7C-8D10-85395EE174CA Q26740628-B6F3D929-6EBD-4779-9BAF-958DDF503D00 Q26748538-8BB8C37E-4BCB-4CEC-8039-40A6740F7D4C Q26774221-426264A8-8FA6-463C-A83A-0D6724B98C90 Q26777310-1454582D-7DB6-4B7E-808A-FF89649A77BB Q26778913-0F11A4E8-E79D-41EE-84AB-E0BE67C947B3 Q26851631-57C36EB0-BEA9-4D33-89B8-18FD97EE692C Q26853635-9ECB4254-8F02-4456-8772-8B000BB842B4 Q27004796-21F24775-B217-4ED7-84DC-5D1BF763FB6F Q27009424-C17C4684-D8CB-4198-8EA2-EAA31F93FDD0 Q27026768-31FDDEC1-2916-4EF3-A640-181001B75FF4 Q27311628-06DD317B-5E59-4F3D-A3E0-D50A9431514E Q27675350-30411FC4-5323-409C-9262-07AF87762A38 Q27687896-4C62E162-BA1B-42F3-9EAB-18BDFDC329C3 Q27851411-5B08309D-7821-4561-9094-74370C03ABE7 Q28076745-E3982842-2BE5-40E0-B020-846A2F121AC1 Q28079918-7C733E67-440C-491B-88E1-919F68E2F320 Q28085759-0AA13A26-948F-41AB-B138-22E864812031 Q28087571-49A8D92A-DAC0-4827-8337-9155B4773E87 Q28269153-57504020-FF76-4264-BD9D-D1313AB9D00F Q28487784-871DEEEC-40BC-4444-9952-CA6A6E35865F Q28508802-9495B2C0-3D00-4660-9C6D-C4C6ACB508F2

P2860

In vivo amplification of the androgen receptor gene and progression of human prostate cancer.

http://www.wikidata.org/entity/Q34314274

description

1995 nî lūn-bûn

@nan

1995 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

1995 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

1995年の論文

@ja

1995年論文

@yue

1995年論文

@zh-hant

1995年論文

@zh-hk

1995年論文

@zh-mo

1995年論文

@zh-tw

1995年论文

@wuu

name

In vivo amplification of the a ...... sion of human prostate cancer.

@ast

In vivo amplification of the a ...... sion of human prostate cancer.

@en

In vivo amplification of the a ...... sion of human prostate cancer.

@nl

type

label

In vivo amplification of the a ...... sion of human prostate cancer.

@ast

In vivo amplification of the a ...... sion of human prostate cancer.

@en

In vivo amplification of the a ...... sion of human prostate cancer.

@nl

prefLabel

In vivo amplification of the a ...... sion of human prostate cancer.

@ast

In vivo amplification of the a ...... sion of human prostate cancer.

@en

In vivo amplification of the a ...... sion of human prostate cancer.

@nl

P1433

Q34314274-1D7D8478-2CD1-42F5-827B-187F0450BC25

P1476

Q34314274-83232930-094D-4EEE-ACA3-AE6E0B03896A

P2093

Q34314274-2CC7AF0E-1057-463E-95AC-7B7C76A79D81

Q34314274-64AEAA9E-DE8D-4CF8-A68E-842129EE638D

Q34314274-7A884D60-EE75-4450-B305-ABEF2DE6131F

Q34314274-88DEAD6A-14A7-4933-99E8-06C0AB2D9644

Q34314274-8D9FA4EA-746F-4EE0-ACB6-D8B53BDAF05A

Q34314274-E81C07D9-1F51-4C1A-AFBB-F0571E4B19CF

Q34314274-FF412646-78E5-4ADD-BFF6-024B7DECDCC7

Q34314274-FFEF65EC-A2A0-408F-926A-3586A2CD5787

P2860

Q34314274-4D724D5D-FA02-4F3D-945A-5F00C3A0A568

Q34314274-D33EF38C-5789-4ABB-86AA-031002A116FF

P2888

Q34314274-DED5A913-2CE5-4541-A5EE-2EC60FBA2A57

P304

Q34314274-8D9264A2-5D4A-4C09-88E2-7D32820878FD

P31

Q34314274-E7B8AC97-A5B0-4385-AA48-B4A643AD0B9A

P356

Q34314274-7D0C99AD-C168-4E81-B39F-41EF0C9A952F

P407

Q34314274-637A76B8-1A8E-4ADA-8E4D-2993DEA40AD6

P433

Q34314274-C33F8A87-28D2-4F4B-AD18-4A6ED0950DA7

P478

Q34314274-6DFDAD49-40AB-4B0B-A741-F4007967CDEA

P50

Q34314274-59C5C418-865E-4774-A54A-C1615E7B0ECC

Q34314274-FB9DBB70-720B-42C4-B787-DE75A552C726

P577

Q34314274-B6DFE79E-A023-4D07-996D-AF28D4B8BC86

P5875

Q34314274-648F9AF7-82A9-4E4D-8E9B-D6FE614D3A25

P6179

Q34314274-BA09C2BD-CC0E-4CB6-B0A7-29AEF6EC172B

P698

Q34314274-0C7961BC-F4D4-4690-BD51-D26674263E8B

P356

P1433

Nature Genetics

P1476

In vivo amplification of the a ...... sion of human prostate cancer.

@en

P2093

Hyytinen E

http://www.w3.org/2001/XMLSchema#string

Isola J

http://www.w3.org/2001/XMLSchema#string

Keinänen R

http://www.w3.org/2001/XMLSchema#string

Koivisto P

http://www.w3.org/2001/XMLSchema#string

Palmberg C

http://www.w3.org/2001/XMLSchema#string

Palotie A

http://www.w3.org/2001/XMLSchema#string

Tammela T

http://www.w3.org/2001/XMLSchema#string

Visakorpi T

http://www.w3.org/2001/XMLSchema#string

P2860

Chromosomal abnormalities and related events in prostate cancer.

A controlled trial of leuprolide with and without flutamide in prostatic carcinoma.

P2888

P304

401-406

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NG0495-401

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Olli-Pekka Kallioniemi

P577

1995-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

15402853

http://www.w3.org/2001/XMLSchema#string

P6179

1021884717

http://www.w3.org/2001/XMLSchema#string

P698

7795646

http://www.w3.org/2001/XMLSchema#string